Dow/Evotec in proteomics deal
Dow AgroSciences has entered into a research collaboration with the German biotechnology company, Evotec (Frankfurt). Dow will use Evotec's chemical proteomics services to support compounds in development. Evotec's Cellular Target Profiling technology will be used to "de-convolute phenotypic screening results", the companies point out. "This collaboration highlights the broad applicability of Evotec's industry-leading chemical proteomics platform to determine cellular target affinities and mechanisms of action on a proteome-wide level and in a native context," says Evotec's chief operating officer, Dr Mario Polywka.